Invention Grant
- Patent Title: DNA aptamer specifically binding to ESAT6, and use thereof
-
Application No.: US16649747Application Date: 2018-09-19
-
Publication No.: US11619633B2Publication Date: 2023-04-04
- Inventor: Yoon-Keun Kim , Changill Ban , Chulhun Chang
- Applicant: MD APTUS INC.
- Applicant Address: KR Seoul
- Assignee: MD APTUS INC.
- Current Assignee: MD APTUS INC.
- Current Assignee Address: KR Seoul
- Agency: Riverside Law LLP
- Priority: KR10-2017-0123384 20170925
- International Application: PCT/KR2018/011066 WO 20180919
- International Announcement: WO2019/059644 WO 20190328
- Main IPC: C07H21/02
- IPC: C07H21/02 ; G01N33/569 ; C12N15/115 ; G01N33/553

Abstract:
The present invention relates to a DNA aptamer binding specifically to early secretory antigenic target 6 kDa (ESAT6), a biosensor for diagnosis of tuberculosis, comprising the same, and a method for providing information for diagnosis of tuberculosis. The present inventors found that not only does a DNA aptamer according to the present invention have specific binding potential to ESAT6 protein, but also the binding affinity is excellent. When used, the DNA aptamer of the present invention can be thus expected to exhibit greater stability than a conventional ELISA method using an antibody. Hence, the aptamer is expected to find useful applications in the development of compositions for tuberculosis diagnosis, biosensors for tuberculosis diagnosis, and information providing methods for tuberculosis diagnosis.
Public/Granted literature
- US20200340992A1 DNA APTAMER SPECIFICALLY BINDING TO ESAT6, AND USE THEREOF Public/Granted day:2020-10-29
Information query